✦ LIBER ✦

Non-dietary therapeutic clinical trials in coeliac disease

✍ Scribed by Laura Crespo Pérez; Gemma Castillejo de Villasante; Ana Cano Ruiz; Francisco León

Book ID: 116432651
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 655 KB
Volume: 23
Category: Article
ISSN: 0953-6205
DOI: 10.1016/j.ejim.2011.08.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dietary compliance in screening-detected

Dietary compliance in screening-detected coeliac disease adolescents

✍ E Fabiani; C Catassi; A Villari; P Gismondi; R Pierdomenico; IM Rätsch; GV Coppa 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Clinical trial methodologies for disease

Clinical trial methodologies for disease-modifying therapeutic approaches

✍ Paul S. Aisen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Clinical trial data provides hope for at

Clinical trial data provides hope for attenuation of mucosal injury in coeliac disease

✍ Laura Crespo Pérez; Francisco León 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Dyslipidaemia and cardiorenal disease: m

Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials

✍ Doris T. Chan; Ashley B. Irish; Gursharan K. Dogra; Gerald F. Watts 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Microcomputers in clinical trials for di

Microcomputers in clinical trials for dietary management

✍ Sandra N. Powers 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Therapeutic trials in neuromuscular dise

Therapeutic trials in neuromuscular diseases

✍ Walter G. Bradley 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

T h e treatment of a disease may spring from an understanding of the underlying etiology of that disease, or it may arise less directly. For instance, the use of L-dopa in the treatment of Parkinson's disease arose from the finding of deficient dopamine levels in the brains o f Parkinsonian patients